Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03087708
Recruitment Status : Active, not recruiting
First Posted : March 22, 2017
Last Update Posted : May 26, 2021
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : December 30, 2020
Estimated Study Completion Date : August 2027